Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Action: Physiological Effects

Lack of Catheter Infection by the efg1/efg1cph1/cph1 Double-Null Mutant, a Candida albicans Strain That Is Defective in Filamentous Growth

Russell E. Lewis, Hsiu-Jung Lo, Issam I. Raad, Dimitrios P. Kontoyiannis
Russell E. Lewis
1Department of Infectious Diseases, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
2University of Houston College of Pharmacy, Houston, Texas 77204
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsiu-Jung Lo
3National Health Research Institutes, Taipei, Taiwan, Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Issam I. Raad
1Department of Infectious Diseases, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dimitrios P. Kontoyiannis
1Department of Infectious Diseases, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dkontoyi@mdanderson.org
DOI: 10.1128/AAC.46.4.1153-1155.2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The molecular controls regulating the successful colonization of Candida albicans on foreign materials are not known. Here we show that a mutant C. albicans strain defective in filamentous growth and lacking the transcription factors Efg1p and Cph1p has a profoundly deficient potential for colonizing on polyurethane catheters.

The central venous catheter is known to be a major reservoir and source for Candida bloodstream infections in hospitalized patients (5). In addition, the ability of Candida species to adhere to foreign materials such as catheters has been well demonstrated (7). However, the molecular controls and environmental cues that regulate successful colonization of Candida spp. on such materials are not fully known. A number of pathogenicity and virulence factors that may contribute to successful colonization of Candida albicans have been proposed; of these, the greatest interest has been paid to the ability of Candida spp. to switch from yeast to filamentous growth. Dimorphism in C. albicans is regulated by at least two pathways, a conserved mitogen-activated protein kinase pathway that modulates the transcription factor Cph1p and a cyclic AMP-protein kinase A pathway that regulates the transcription factor Efg1p (2). A mutant C. albicans strain lacking both the transcription factors Efg1p (9) and Cph1p (3) is profoundly defective in filamentous growth (4), even though an Efg1p- and Cph1p-independent pathway for filamentous growth exists (6). We examined the abilities of the efg1/efg1 cph1/cph1 double-null mutant and the efg1/efg1 cph1/cph1 double mutant with the wild-type EFG1 gene in the genome, as well as those of the cph1/cph1 and efg1/efg1 single mutants and isogenic wild-type C. albicans strains, to colonize on foreign materials (polyurethane catheters).

The strains used in this study and their genotypes were as follows: CAI4, ura3::1 imm434/ura3::1 imm434; JKC18, ura3::1 im434/ura3::1 imm434 cph1::hisG/cph1::hisG-URA3-hisG; HLC67, ura3::1 imm434/ura3::1 imm434 efg1::hisG/efg1::hisG-URA3-hisG; HLC69, ura3::1 imm434/ura3::1 imm434 cph1::hisG/cph1::hisG efg1::hisG/efg1::hisG-URA3-hisG; andHLC84, ura3::1 imm434/ura3::1 imm434 cph1::hisG/cph1::hisG efg1::hisG/efg1::hisG (EFG1-URA3) (see reference 1 for strain CAI4, reference 3 for strain JKC18, and reference 4 for the remaining strains). Human plasma (10 ml) was injected through the lumen ports of single-lumen 7-French polyurethane catheters (Cook Catheters, Bloomington, Ind.), which were then incubated at 35°C for 24 h. Next, the catheters were removed from the plasma and placed in a culture medium (RPMI 1640 plus 0.165 M MOPS [morpholinepropanesulfonic acid]; pH 7.0) containing standardized suspensions (105 CFU/ml) of the C. albicans strains tested that were prepared from a 24-h culture plate. After incubation (35°C) in this medium for an additional 24 h, the catheters were carefully removed and flushed via the lumen with 100 ml of sterile saline. The catheters were then placed in a separate sterile culture tube containing 10 ml of sterile saline and gently vortexed to remove nonadherent organisms from outside the catheter lumen. The catheters were subsequently removed from the saline, aseptically cut at the 6-cm mark (on the catheter lumen), and placed in 10 ml of fresh sterile culture medium. The culture tubes were then sonicated (55,000 Hz) for 5 min to remove adherent organisms (8). After an additional 15 s of vortexing, a 50-μl sample of the culture medium was removed to a potato dextrose agar (Remel, Lenexa, Kans.) plate using a spiral-gradient plating system (Spiral Biotech Inc., Bethesda, Md.). The numbers of viable CFU per milliliter of medium were determined according to the colony counts after 24- and 48-h incubations at 35°C. To further characterize the phenotype of catheter attachments by the wild-type and mutant C. albicans strains, experiments were repeated as described above except that the 6-cm catheter segment was placed in 4% glutaraldehyde in a 0.1 M sodium cacodylate buffer, pH 7.2. Catheter sections (2 cm) were then fixed in osmium tetroxide and dehydrated using a graded series of ethanol washings followed by immersion in hexamethyldisilazane. Next, the sections were air dried, mounted onto aluminum stubs, and sputter-coated with Pd and Au. A Hitachi S4000 scanning electron microscope (Hitachi Scientific Instruments, Mountain View, Calif.) was used for visualization of the samples. All C. albicans strains were tested simultaneously, and experiments were performed in triplicate. Mean data (CFU per milliliter)were compared using analysis of variance along with the Tukey's test for post hoc comparisons.

The efg1/efg1 cph1/cph1 double-mutant strain was defective in its ability to colonize on the polyurethane catheters. Specifically, the mean number of viable CFU per milliliter recovered from the sonicated catheter segments was 3 to 4 log10 lower for the double-mutant strain versus the wild-type strain (P = 0.01) (Fig. 1). The efg1/efg1 and cph1/cph1 single-mutant strains had an intermediate phenotype, having a mean number of viable CFU per milliliter recovered from the segments that was about 1 log10 higher than that for the double-mutant strain (Fig. 1). When catheters were examined by scanning electron microscopy, decreased colonization was noted by the efg1/efg1 cph1/cph1 double mutant, with occasional blastoconidia but no hyphal forms (Fig. 2).

Of the two major signaling pathways controlling hyphal growth, the Efg1p pathway appears more important since egf1/efg1 mutants demonstrate a more severe morphogenetic block under most inducing conditions (4). Furthermore, egf1/efg1 mutants are much less virulent than the cph1/cph1 mutants in the mouse model of candidiasis (4). Our observation that the efg1/efg1 mutant had more-severe adherence defects than the cph1/cph1 mutant is consistent with these prior observations. Nevertheless, the efg1/efg1 cph1/cph1 double mutant has the most severe morphogenetic and virulence defects (4). Such morphogenetic defects were also observed in our study. The presence of the wild-type EFG1 gene integrated in the genome of the efg1/efg1 cph1/cph1 double mutant (HLC84) caused the formation of germ tubes and pseudohyphae (4). The ability of the efg1/efg1 cph1/cph1 double mutant to colonize was restored to the level of the cph1/cph1 single mutant by integrating the wild-type EFG1 gene in the genome (Fig. 1). Therefore, our observation is consistent with the hypothesis that Cph1p and Efg1p govern catheter colonization ability.

One of the limitations of our approach is that we did not evaluate fully the possibility of another, secondary mutation giving the phenotype observed. However, we think that it is unlikely that another mutation could affect the phenotypic characteristics in two genotypically different strains such as efg1/efg1 and cph1/cph1. In addition, our preliminary data do not address which of the rather-complex and interrelated early events of catheter colonization, such as adherence and biofilm formation, are regulated predominantly by EFG1 and CPH1.

In conclusion, both Efg1p and Cph1p appear to be central regulators of the developmental program that allows C. albicans to successfully colonize on foreign materials such as polyurethane central venous catheters. It is possible that interruption of morphogenetic events induced by Efg1p and Cph1p through pharmacological or other means could affect the fitness of C. albicans to successfully colonize prosthetic materials or central venous catheters.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Comparison of the colonization intensities (polyurethane central venous catheters) of C. albicans strains with the following genotypes: isogenic wild-type (CAI4), efg1/efg1 (HLC67) and cph1/cph1 (JKC18) single mutants, efg1/efg1 cph1/cph1 double mutant (HLC69), and efg1/efg1 cph1/cph1 with the wild-type EFG1 gene (HLC84). Counts were analyzed by nonparametric Kruskal-Wallis one-way analysis of variance on ranks by using Dunn's pairwise multiple-comparison technique (Sigmastat statistical software, version 2.0; SPSS Science, Chicago, Ill.).

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Scanning electron micrographs (magnification, ×1,000) of exterior catheter lumens exposed to the wild-type (CAI4) and efg1/efg1cph1/cph1 double-mutant (HLC69) C. albicans strains.

FOOTNOTES

    • Received 7 November 2001.
    • Returned for modification 10 December 2001.
    • Accepted 2 January 2002.
  • Copyright © 2002 American Society for Microbiology

REFERENCES

  1. 1.↵
    Fonzi, W. A., and M. Y. Irwin, 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics134:717-728.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Lengeler, K. B., R. C. Davidson, C. D'Sousa, et al. 2000. Signal transduction regulating fungal development and virulence. Microbiol. Mol. Biol. Rev.64:746-785.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Liu, H., J. Kohler, and G. R. Fink. 1994. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science266:1723-1726.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Lo, H. J., J. R. Kohler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell90:939-949.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Pfaller, M. A. 1996. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin. Infect. Dis.22(Suppl. 2):S89-S94.
  6. 6.↵
    Riggle, P. J., K. A. Andrutis, X. Chen, S. R. Tzipori, and C. A. Kumamoto. 1999. Invasive lesions containing filamentous forms produced by a Candida albicans mutant that is defective in filamentous growth in culture. Infect. Immun.67:3649-3652.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Rotrosen, D., T. R. Gibson, and J. E. Edwards, Jr. 1983. Adherence of Candida species to intravenous catheters. J. Infect. Dis.147:594.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Sherertz, R. J., I. I. Raad, A. Belani, L. C. Koo, K. H. Rand, D. L. Pickett, S. A. Straub, and L. L. Fauerbach. 1990. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J. Clin. Microbiol.28:76-82.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Stoldt, V. R., A. Sonneborn, C. E. Leuker, and J. F. Ernst. 1997. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J.16:1982-1991.
    OpenUrlAbstract
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Lack of Catheter Infection by the efg1/efg1cph1/cph1 Double-Null Mutant, a Candida albicans Strain That Is Defective in Filamentous Growth
Russell E. Lewis, Hsiu-Jung Lo, Issam I. Raad, Dimitrios P. Kontoyiannis
Antimicrobial Agents and Chemotherapy Apr 2002, 46 (4) 1153-1155; DOI: 10.1128/AAC.46.4.1153-1155.2002

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Lack of Catheter Infection by the efg1/efg1cph1/cph1 Double-Null Mutant, a Candida albicans Strain That Is Defective in Filamentous Growth
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Lack of Catheter Infection by the efg1/efg1cph1/cph1 Double-Null Mutant, a Candida albicans Strain That Is Defective in Filamentous Growth
Russell E. Lewis, Hsiu-Jung Lo, Issam I. Raad, Dimitrios P. Kontoyiannis
Antimicrobial Agents and Chemotherapy Apr 2002, 46 (4) 1153-1155; DOI: 10.1128/AAC.46.4.1153-1155.2002
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Candida albicans
Catheterization
DNA-Binding Proteins
Fungal Proteins
transcription factors

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596